13D Filing: Starboard Value LP and Depomed Inc (NASDAQ:DEPO)

Page 1 of 25

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
STARBOARD VALUE 5,490,000 5,490,000 5,490,000 5,490,000 5,490,000 8.8%
STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD 4,233,717 5,490,000 4,233,717 5,490,000 4,233,717 6.8%
STARBOARD VALUE AND OPPORTUNITY S 499,512 5,490,000 499,512 5,490,000 499,512 Less than 1%
STARBOARD VALUE AND OPPORTUNITY C 277,452 277,452 277,452 Less than 1%
STARBOARD VALUE R 277,452 277,452 277,452 Less than 1%
STARBOARD VALUE R GP 277,452 277,452 277,452 Less than 1%
STARBOARD VALUE GP 5,490,000 5,490,000 5,490,000 8.8%
STARBOARD PRINCIPAL CO 5,490,000 5,490,000 5,490,000 8.8%
STARBOARD PRINCIPAL CO GP 5,490,000 5,490,000 5,490,000 8.8%
JEFFREY C. SMITH 1,626 1,626 5,490,000 8.8%
MARK R. MITCHELL 5,490,000 8.8%
PETER A. FELD 5,490,000 8.8%
GAVIN T. MOLINELLI 1,626 Less than 1%

Follow Jeff Smith's Starboard Value LP

Page 1 of 25 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 6)1
Depomed, Inc.
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
249908104
(CUSIP Number)
JEFFREY C. SMITH
STARBOARD VALUE LP
777 Third Avenue, 18th Floor
New York, New York 10017
(212) 845-7977
STEVE WOLOSKY, ESQ.
OLSHAN FROME WOLOSKY LLP
1325 Avenue of the Americas
New York, New York 10019
(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)
March 28, 2017
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
_______________
1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 1 of 25